- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic migraine
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Erenumab – March 2019
Erenumab: Injection 70 mg in 1 mL single dose pre-filled pen; Aimovig®
Last updated
5 July 2019